Cargando…

The Effect of Adherence to Screening Guidelines on the Risk of Alzheimer’s Disease in Elderly Individuals Newly Diagnosed With Type 2 Diabetes Mellitus

Objective: The aim of this study was to examine the possibility that type 2 diabetes and Alzheimer’s disease may share common behavioral protective factors such as adherence to type 2 diabetes treatment guidelines given that these two diseases have both epidemiological and metabolic similarities. Me...

Descripción completa

Detalles Bibliográficos
Autores principales: Yashkin, Arseniy P., Akushevich, Igor, Ukraintseva, Svetlana, Yashin, Anatoliy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6236474/
https://www.ncbi.nlm.nih.gov/pubmed/30450369
http://dx.doi.org/10.1177/2333721418811201
_version_ 1783371040025477120
author Yashkin, Arseniy P.
Akushevich, Igor
Ukraintseva, Svetlana
Yashin, Anatoliy
author_facet Yashkin, Arseniy P.
Akushevich, Igor
Ukraintseva, Svetlana
Yashin, Anatoliy
author_sort Yashkin, Arseniy P.
collection PubMed
description Objective: The aim of this study was to examine the possibility that type 2 diabetes and Alzheimer’s disease may share common behavioral protective factors such as adherence to type 2 diabetes treatment guidelines given that these two diseases have both epidemiological and metabolic similarities. Method: The method used in this study is a retrospective cohort study of 3,797 U.S. Medicare fee-for-service beneficiaries aged 66+ newly diagnosed with type 2 diabetes and without a prior record of Alzheimer’s disease based on the Health and Retirement Study. Results: Results of a left-truncated Cox model showed that adherence reduces the risk of Alzheimer’s disease by 20% to 24%. Other significant effects were college education (hazard ratio [HR]: 0.65; p value: .023), stroke (HR: 1.40; p value: .013), and 4+ limitations in physical functioning (HR: 1.33; p value: .008). Discussion: Risk of Alzheimer’s disease can be reduced by behavioral factors. Possible mechanisms may include earlier start of interventions to reduce blood glucose levels and improve insulin sensitivity.
format Online
Article
Text
id pubmed-6236474
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-62364742018-11-16 The Effect of Adherence to Screening Guidelines on the Risk of Alzheimer’s Disease in Elderly Individuals Newly Diagnosed With Type 2 Diabetes Mellitus Yashkin, Arseniy P. Akushevich, Igor Ukraintseva, Svetlana Yashin, Anatoliy Gerontol Geriatr Med Article Objective: The aim of this study was to examine the possibility that type 2 diabetes and Alzheimer’s disease may share common behavioral protective factors such as adherence to type 2 diabetes treatment guidelines given that these two diseases have both epidemiological and metabolic similarities. Method: The method used in this study is a retrospective cohort study of 3,797 U.S. Medicare fee-for-service beneficiaries aged 66+ newly diagnosed with type 2 diabetes and without a prior record of Alzheimer’s disease based on the Health and Retirement Study. Results: Results of a left-truncated Cox model showed that adherence reduces the risk of Alzheimer’s disease by 20% to 24%. Other significant effects were college education (hazard ratio [HR]: 0.65; p value: .023), stroke (HR: 1.40; p value: .013), and 4+ limitations in physical functioning (HR: 1.33; p value: .008). Discussion: Risk of Alzheimer’s disease can be reduced by behavioral factors. Possible mechanisms may include earlier start of interventions to reduce blood glucose levels and improve insulin sensitivity. SAGE Publications 2018-11-13 /pmc/articles/PMC6236474/ /pubmed/30450369 http://dx.doi.org/10.1177/2333721418811201 Text en © The Author(s) 2018 http://www.creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Article
Yashkin, Arseniy P.
Akushevich, Igor
Ukraintseva, Svetlana
Yashin, Anatoliy
The Effect of Adherence to Screening Guidelines on the Risk of Alzheimer’s Disease in Elderly Individuals Newly Diagnosed With Type 2 Diabetes Mellitus
title The Effect of Adherence to Screening Guidelines on the Risk of Alzheimer’s Disease in Elderly Individuals Newly Diagnosed With Type 2 Diabetes Mellitus
title_full The Effect of Adherence to Screening Guidelines on the Risk of Alzheimer’s Disease in Elderly Individuals Newly Diagnosed With Type 2 Diabetes Mellitus
title_fullStr The Effect of Adherence to Screening Guidelines on the Risk of Alzheimer’s Disease in Elderly Individuals Newly Diagnosed With Type 2 Diabetes Mellitus
title_full_unstemmed The Effect of Adherence to Screening Guidelines on the Risk of Alzheimer’s Disease in Elderly Individuals Newly Diagnosed With Type 2 Diabetes Mellitus
title_short The Effect of Adherence to Screening Guidelines on the Risk of Alzheimer’s Disease in Elderly Individuals Newly Diagnosed With Type 2 Diabetes Mellitus
title_sort effect of adherence to screening guidelines on the risk of alzheimer’s disease in elderly individuals newly diagnosed with type 2 diabetes mellitus
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6236474/
https://www.ncbi.nlm.nih.gov/pubmed/30450369
http://dx.doi.org/10.1177/2333721418811201
work_keys_str_mv AT yashkinarseniyp theeffectofadherencetoscreeningguidelinesontheriskofalzheimersdiseaseinelderlyindividualsnewlydiagnosedwithtype2diabetesmellitus
AT akushevichigor theeffectofadherencetoscreeningguidelinesontheriskofalzheimersdiseaseinelderlyindividualsnewlydiagnosedwithtype2diabetesmellitus
AT ukraintsevasvetlana theeffectofadherencetoscreeningguidelinesontheriskofalzheimersdiseaseinelderlyindividualsnewlydiagnosedwithtype2diabetesmellitus
AT yashinanatoliy theeffectofadherencetoscreeningguidelinesontheriskofalzheimersdiseaseinelderlyindividualsnewlydiagnosedwithtype2diabetesmellitus
AT yashkinarseniyp effectofadherencetoscreeningguidelinesontheriskofalzheimersdiseaseinelderlyindividualsnewlydiagnosedwithtype2diabetesmellitus
AT akushevichigor effectofadherencetoscreeningguidelinesontheriskofalzheimersdiseaseinelderlyindividualsnewlydiagnosedwithtype2diabetesmellitus
AT ukraintsevasvetlana effectofadherencetoscreeningguidelinesontheriskofalzheimersdiseaseinelderlyindividualsnewlydiagnosedwithtype2diabetesmellitus
AT yashinanatoliy effectofadherencetoscreeningguidelinesontheriskofalzheimersdiseaseinelderlyindividualsnewlydiagnosedwithtype2diabetesmellitus